| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587044 | Diabetes Research and Clinical Practice | 2017 | 8 Pages |
Abstract
The results of clinical trials summarized in the present meta-analysis reassure us that, when the drug is properly prescribed, the risk of DKA is negligible.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Matteo Monami, Besmir Nreu, Stefania Zannoni, Carlotta Lualdi, Edoardo Mannucci,